Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance

Clinical Cancer Research

Volumn 8, Issue 12, 2002, Pages 3755-3760

  Tomiyasu, Makiko ^a   Yoshino, Ichiro ^a   Suemitsu, Ryuichi ^a   Okamoto, Tatsuro ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ARTICLE; CANCER STAGING; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA;

CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUNG; LUNG NEOPLASMS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0036898615     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bloom, B. R., and Bennett, B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (Wash. DC), 153: 80-82, 1966.
2. David, J. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA, 56: 72-77, 1996.
3. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature (Lond.), 365: 756-759, 1993.
4. Calandra, T., Bernhagen, J., Mitchell, R. A., and Bucala, R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med., 179: 1895-1902, 1994.
5. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature (Lond.), 377: 68-71, 1995.
6. Shimizu, T., Ohkawara, A., Nishihira, J., and Sakamoto, W. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett., 381: 199-202, 1996.
7. Matsuda, A., Tagawa, Y., Yoshida, K., Matsuda, H., and Nishihara, J. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human cornea. FEBS Lett., 385: 225-228, 1996.
8. Ogata, A., Nishihara, J., Suzuki, T., Nagashima, K., and Tashiro, K. Identification of macrophage migration inhibitory factor (MIF) mRNA expression in neural cells of the rat brain by in situ hybridization. Neurosci. Lett., 249: 173-177, 1998.
9. Imamura, K., Nishihara, J., Suzuki, M., Yasuda, K., Sasaki, S., and Kusunoki, Y. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney. Biochem. Mol. Biol. Int., 40: 1233-1242, 1996.
10. Donnelly, S. C., Haslett, C., Reid, P. T., Grant, I. S., Wallace, W. A. H., Metz, C. N., Bruce, L. J., and Bucala, R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med., 3: 320-323, 1997.
11. Wistow, G. J., Shaughnessy, M. P., Lee, D. C., Hodin, J., and Zalenka, P. S. A macrophage migration inhibitory factor is expressed in the differentiation cells of the eye lens. Proc. Natl. Acad. Sci. USA, 90: 1272-1275, 1993.
12. Gordon, L. I., and Weitzman, S. A. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood, 76: 655-663, 1990.
13. Christen, S., Hagen, T. M., Shigehara, M. K., and Ames, B. N. Chronic infection and inflammation leads to cancer. In: Microbes and Malignancy: Infection as a Cause of Cancer pp. 35-88 (Parsonnet, J., and Homing, S., eds.). Oxford: Oxford University Press, 1999.
14. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., and Beach, D. H. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med., 190: 1375-1382, 1999.
15. Shimizu, T., Abe, R., Nakamura, H., Ohkawara, A., Suzuki, M., and Nishihira, J. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem. Biophys. Res. Commun., 264: 751-758, 1999.
16. Nishihira, J., Koyama, Y., and Mizue, Y. Identification of macrophage migration inhibitory factor in human leukemia HL-60 cells and its induction by lipopolysaccharide. Biochem. Mol. Biol. Int., 40: 861-869, 1996.
17. Meyer-Siegler, K., and Hudson, P. B. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology, 48: 448-452, 1996.
18. Bini, L., Mgi, B., Marzocchi, B., Arcuri, F., Tripodi, S., and Cintorino, M. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis, 18: 2832-2841. 1997.
19. Takahashi, N., Nishihara, J., Sato, Y., Kondo, M., Ogawa, H., and Ohshima, T. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol. Med., 4: 707-714, 1998.
20. Kamimura, A., Kamachi, M., Nishihira, J., Ogura, S., Isobe, H., Dosaka-Akita, H., Shindoh, M., Ohbuchi, T., and Kawakami, Y. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer (Phila.), 89: 334-341, 2000.
21. Cordon, C. C., and Prives, C. At the crossroads of inflammation and tumorigenesis. J. Exp. Med., 190: 1367-1370, 1999.
22. Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger, K. A., Flieger, O., Johannes, F. J., Roger, T., Calandra, T., Kapurniotu, A., Grell, M., Finkelmeier, D., Brunner, H., and Bernhagen, J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jabl. Nature (Lond.), 408: 211-216, 2000.
23. kip1 correlates with a shortened survival in non-small cell lung cancer. Lung Cancer, 34: 83-90, 2001.
24. Pozzi, L. A., and Weiser, W. Y. Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell. Immunol., 145: 372-379, 1992.
25. White, E. S., Strom, S. R. B., Wys, N. L., and Arenberg, D. A. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J. Immunol., 166: 7549-7555, 2001.
26. Ogawa, H., Nishihara, J. Sato, Y., Knodo, M., Takahashi, N., Oshima, T., and Todo, S. An antibody for macrophage migration inhibitory factor suppresses tumor growth and inhibits tumor-associated angiogenesis. Cytokine, 12: 309-314, 2000.
27. Wistuba, I. I., Lam, S., Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., Samet, J. M., Srivastava, S., Minna, J. D., and Gazder, A. F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. (Bethesda), 89: 1366-1373, 1997.
28. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. (Bethesda), 89: 857-862, 1997.
29. Fong, K. M., Zimmerman, P. V., and Smith, P. J. Correlation of loss of heterozygosity at 11p with tumor progression and survival in nonsmall cell lung cancer. Genes Chromosomes Cancer, 10: 183-189, 1994.
30. Yoshino, I., Baba, H., Fukuyama, S., Kameyama, T., Shikada, Y., Tomiyasu, M., and Suemitsu. R. A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer. Surgery (St. Louis), 131: 242-248, 2002.